EUVIMEDEUVIMED entdecken
Crossref

Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice

Molly A Mendenhall iD, Andrew Guinigundo, Dan Davies, Patrick Ward iD, David R Drosick iD, David M Waterhouse iD

JCO Oncology Practice · 2024

DOI: 10.1200/op.22.00794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2024. Verfasst von Molly A Mendenhall und 5 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Hematology Care (OHC), Cincinnati, OH. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Despite data-driven consensus recommendations, there remains significant nonadherence to genetic screening and testing. More than 300,000 patients are diagnosed with breast cancer annually, with one third of these estimated to be eligible for homologous recombination deficiency (HRD)/BRCA testing following National Comprehensive Cancer Network (NCCN) guidelines. Only 35% of eligible patients are referred for genetic counseling. METHODS The goal of this project was to apply NCCN guidelines for germline genetic testing to all new patients with breast cancer within a large community oncology practice to improve HRD/BRCA testing. Plan-Do-Study-Act methodology was used, and cycles were built on a proven teaching infrastructure. In cycle 1, providers were educated and directed to use electronic health record (EHR) templates in the setting of an initial diagnosis visit and treatment planning. Discreet data fields were created in the EHR during cycle 2 to streamline and automate the process. Appropriate patients were referred to the genetics team for further evaluation, counseling, and testing. Adherence to the plan was maintained and measured using data analytic reports and chart audits. RESULTS Of the 1,203 patients with breast cancer eligible for inclusion, 1,200 (99%) were screened according to NCCN guidelines. Of the screened patients, 631 (52.5%) met the referral/testing criteria. In total, 585 (92.7%) of the 631 were referred to a genetic specialist. Seven percent had previous referrals. A total of 449 (71%) patients were acceptable to genetics referral while 136 (21.5%) patients refused. CONCLUSION The implemented methods of education, NCCN guidelines imbedded within provider notes, and discreet data fields in the EHR have proven to be highly effective in screening appropriate patients and ordering subsequent genetic referrals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleGenetic TestingGenetic CounselingDelivery of Health CareCounseling

Autor:innen und Institutionen

  • Oncology Hematology Care (OHC), Cincinnati, OH.
  • Cincinnati Cancer Advisors, Cincinnati, OH.

ORCID-Profile: Molly A Mendenhall, Patrick Ward, David R Drosick, David M Waterhouse

Zitieren

APA

Mendenhall, M. A., Guinigundo, A., Davies, D., Ward, P., Drosick, D. R., & Waterhouse, D. M. (2024). Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice. JCO Oncology Practice. https://doi.org/10.1200/op.22.00794

Vancouver

Mendenhall MA, Guinigundo A, Davies D, Ward P, Drosick DR, Waterhouse DM. Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice. JCO Oncology Practice. 2024. doi:10.1200/op.22.00794

BibTeX
@article{Mendenhall2024,
  author = {Mendenhall, Molly A and Guinigundo, Andrew and Davies, Dan and Ward, Patrick and Drosick, David R and Waterhouse, David M},
  title = {Integration of Genetic Testing and Counseling in Patients With Breast Cancer in a Large, Multisite Community-Based Practice},
  journal = {JCO Oncology Practice},
  year = {2024},
  doi = {10.1200/op.22.00794}
}
Kostenlos starten →